Open Access
Article
TNF-alpha enhances engraftment of mesenchymal stem cells into infarcted myocardium
Yong Sook Kim1,Hye Jung Park1,Moon Hwa Hong1,Peter M Kang1,James P Morgan1,Myung Ho Jeong1,Jeong Gwan Cho1,Jong Chun Park1,Youngkeun Ahn1
1
Cardiovascular Research Institute, Chonnam National University, Gwanju, South Korea
DOI: 10.2741/3417 Volume 14 Issue 8, pp.2845-2856
Published: 01 January 2009
(This article belongs to the Special Issue Genetic and cellular therapies in cardiovascular diseases)
Abstract

TNF-alpha released from ischemic heart after acute MI increases the production of other cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6) and adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1). Activation of nuclear factor kappa B (NF-kappa B) by TNF-alpha , up-regulates the expression of molecules which are involved in inflammation and cell adhesion. For these reasons, we assessed the extent that treatment of MSC with tumor necrosis factor (TNF)-alpha modifies the characteristics of MSC, important to their engraftment in experimental myocardial infarct. Here, we show that pre-treatment of MSC prior to transplantation with tumor necrosis factor (TNF)-alpha increases adhesiveness, and migration of MSC in vitro and leads to increased expression of bone morphogenetic protein (BMP)-2 by MSC. Moreover, this treatment increases the rate of engraftment of MSC and improves recovery of cardiac function after myocardial infarction. These insights might provide better strategies for the treatment of myocardial infarction.

Share and Cite
Yong Sook Kim, Hye Jung Park, Moon Hwa Hong, Peter M Kang, James P Morgan, Myung Ho Jeong, Jeong Gwan Cho, Jong Chun Park, Youngkeun Ahn. TNF-alpha enhances engraftment of mesenchymal stem cells into infarcted myocardium. Frontiers in Bioscience-Landmark. 2009. 14(8); 2845-2856.